Lori Freedman bought $725k of ORGO
Chief Admin. and Legal Officer at Organogenesis Holdings Inc.. 252,264 shares at an average of $2.88, traded Jun 4, 2025, filed Jun 6, 2025.
Score components
- +15RoleOfficer
- +21Trade size$725k at market
- +6Relative to holdingsHoldings up 42%
- +8Price context54% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +40.3%, 3m +65.0%, 6m +56.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-25-011161, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 4, 2025 | POpen-market purchase Class A Common Stock | +100,863 | $2.82 | $285k | 695,058 | Jun 6, 2025 |
| Jun 5, 2025 | POpen-market purchase Class A Common Stock | +142,379 | $2.91 | $414k | 837,437 | Jun 6, 2025 |
| Jun 6, 2025 | POpen-market purchase Class A Common Stock | +9,022 | $2.99 | $27k | 846,459 | Jun 6, 2025 |
Related signals
Other insiders at Organogenesis Holdings Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | Organogenesis Holdings Inc. | Michael Joseph Driscoll director | $27k 10,000 shares | +5% | |
| 41Moderate | Organogenesis Holdings Inc. | Arthur S Leibowitz director | $13k 5,000 shares | +2% | |
| 40Moderate | ORGOsell Organogenesis Holdings Inc. | Glenn H Nussdorf director | $1.0M 200,000 shares | -7% | |
| 40Moderate | ORGOsell Organogenesis Holdings Inc. | Glenn H Nussdorf director, owner | $1.6M 300,000 shares | -10% | |
| 56Moderate | ORGObuy Organogenesis Holdings Inc. | Glenn H Nussdorf director, owner | $1.1M 358,495 shares | - | |
| 24Weak | ORGOsell Organogenesis Holdings Inc. | Glenn H Nussdorf director, owner | $81k 22,776 shares | -6% | |
| 31Weak | ORGOsell Organogenesis Holdings Inc. | Michael Joseph Driscoll director | $128k 25,000 shares | -13% | |
| 37Weak | ORGOsell Organogenesis Holdings Inc. | Gary S. Gillheeney President and CEO | $206k 61,200 shares | -2% | |
| 49Moderate | ORGOsell Organogenesis Holdings Inc. | Gary S. Gillheeney President and CEO | $940k 259,332 shares | -8% | |
| 22Weak | ORGOsell Organogenesis Holdings Inc. | Gary S. Gillheeney President and CEO | $212k 59,468 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.